Arsenal is a leading private equity firm that specializes in investments in middle-market specialty industrials and healthcare companies.

Investment Management

Arsenal Capital Partners

Christopher Dudley

Chris Huetsch

Jeremy Friedman

Israel Alguindigue

Ms. Dyatlova is a Senior Accountant of Arsenal.  Prior to joining Arsenal in 2023, she was a Senior Associate of IQ-EQ.  Previously, Ms. Dyatlova was Senior Auditor in the financial services group of EisnerAmper LLP.

Elena Dyatlova

Dr. Kennedy is an Operating Partner for the healthcare team.  Prior to joining Arsenal in 2022, he was a Managing Partner of Blue Ox Healthcare Partners, an investment firm focused on life sciences and medical technologies sectors.  Previously, Dr. Kennedy was the Chief Population Health Officer of Healthagen, Aetna’s healthcare IT subsidiary, and CEO of Aetna’s Accountable Care Solutions division.  Prior to Aetna, he served in executive leadership positions as the CEO of Anthem’s HealthCore subsidiary, Vice President of Health IT for Wellpoint, CEO of CareAssured, and Director of Strategic Informatics of Blue Shield of California.  Previously, Dr. Kennedy was a practicing physician at Kaiser Permanent and other Northern Californian medical facilities for seven years.

Charles D. Kennedy

Mr. Rock is an Operating Partner of Arsenal for the industrial growth team.  Prior to joining Arsenal in 2023, he was the CEO and President of Seegrid Corporation, a leading provider of autonomous mobile robots and related enterprise software for material handling.  Previously, he was the President of Vocollect Healthcare, a provider of mobile devices and software for skilled nursing facilities and hospitals that was acquired by Honeywell.  Mr. Rock also co-founded Akustica, Inc., a global consumer electronics semiconductor company, where he served as CEO and President.  Akustica was acquired by Robert Bosch GmbH.

Jim Rock

Ms. Salazar is an Administrative Assistant of Arsenal.  Prior to joining Arsenal in 2022, she was an Administrative Assistant at RedBird Capital Partners.  Previously, she was an Executive Assistant of Offit Capital.

Crystal Salazar

Mr. Kinell is a Senior Advisor for the healthcare team.  He has over 35 years of experience in the pharmaceutical services industry, most recently serving as the CEO of Bracket Global (now Signant Health), an e-clinical software company.  Prior to joining Bracket Global, Mr. Kinell was the CEO of CRI Lifetree, a specialized clinical research site business.  Earlier in his career, he served as the Chief Financial Officer of a provider of post-acute care services, a founder and Co-CEO of a behavioral health company providing services in rehabilitation centers, and a principal with Ernst & Young.

Jeffrey Kinell

Mr. Williamson is a Senior Advisor for the healthcare team.  He was the former CEO and Director at Kaléo, a pharmaceutical manufacturer, for 15 years and was also a Director at Avenu Medical.  Previously, he held executive positions at Boston Scientific and Guidant Corporation.  Mr. Williamson began his career at Eli Lilly after serving in the U.S. Navy.  In 2013, he won the Ernst & Young Entrepreneur of the Year Award.

Spencer Williamson

Ms. Adler is a Vice President, Investor Relations of Arsenal where she focuses on fundraising, managing relationships with investors, marketing, and branding. Prior to joining Arsenal in 2022, she was a Principal, Investor Relations of Centerbridge Partners, L.P. and before that, a member of Cleary Gottlieb Steen & Hamilton LLP's private funds group.

Chelsea Adler

Mr. Bruck is a Vice President of Arsenal for the industrial growth team. Prior to joining Arsenal in 2022, Mr. Bruck was a Vice President for Cerberus Capital Management. Previously, he was an Investment Banking Analyst at Citigroup.

Daniel Bruck

Ms. Critchfield-Jain is a Vice President of Arsenal for the healthcare team. Prior to joining Arsenal in 2022, she was a Vice President at Tailwind Capital.  Previously, Ms. Critchfield-Jain was an Associate of Thompson Street Capital Partners.

Sophie Critchfield-Jain

Mr. Tremblay is an Operating Partner of Arsenal for the industrial growth team. Prior to joining Arsenal in 2022, he was the President of the Fluke Corporation, a global manufacturer and developer of electronic test tools, sensors, and software.  Prior to joining Fluke Corporation in 2019, Mr. Tremblay held numerous senior executive positions at leading testing, measurement, sensing, and imaging companies such as Thermo Fisher Scientific, DigitalGlobe, and Z Corporation.

Marc Tremblay

Martin Coulter is an Operating Partner for the healthcare team. Prior to joining Arsenal in 2022, he was an Operating Partner of TPG Growth and The Rise Fund.  Previously, Martin was the CEO of PatientsLikeMe, a personalized patient health network, and before that, was an Executive Vice President and General Manager for The Advisory Board Company, a healthcare technology and services firm, where he led the performance technology division.  

Martin Coulter

Ms. Ismail is an Executive Assistant. Prior to joining Arsenal in 2022, she was the Executive Assistant at Cain International. Previously, she was the Administrative Assistant/Office Mananger of Proglogis and Office Coordinator of IPSOS North America.

Raha Ismail

Ms. St. Louis is an Executive Assistant of Arsenal.  Prior to joining Arsenal in 2022, she was a Human Capital Executive Assistant of General Atlantic.  Previously, she was an Administrative Assistant of AllianceBernstein and an Administrative Assistant of Baron Capital.

Christina St. Louis

Mr. Graham is a Director, Finance where he focuses on finance and tax projects across a sub-set of existing and prospective industrial growth portfolio companies.  Previously, he was the Chief Financial Officer and a Transaction Partner of Arenal Capital, a distressed investing firm where he helped establish the finance and operations functions of the firm.  Prior to that, Mr. Graham was a Managing Member of Maharg Advisory, a firm dedicated to helping small- and middle-market companies with financial accounting due diligence.  He was also a Managing Director in transaction advisory services for Duff & Phelps.

Steve Graham

Mr. Feuereisen is a Senior Associate,  Research where he focuses on researching investment strategies for the healthcare team.  Prior to joining in 2022, he was a Senior Associate at American Securities.  Previously, Mr. Feuereisen was a Consultant at The Boston Consulting Group.

James Feuereisen

Mr. O’Sullivan is an Associate for the industrial growth team. Prior to joining Arsenal in 2022, he was an Analyst at Graham Partners.

Daniel O'Sullivan

Mr. Nolan is an Associate for the healthcare team. Prior to joining Arsenal in 2022, he was an Associate in investment banking at Goldman Sachs.  Previously, Jack was an Associate in investment banking at J.P.Morgan.

Jack Nolan

Ms. Harris is an Associate for the industrial growth team.  Prior to joining Arsenal in 2022, she was an investment banking Analyst at Jefferies LLC.

LaRae Harris

Mr. Wang is an Associate of Arsenal for the healthcare team.  Prior to joing Arsenal in 2022, he was an investment banking Associate at J.P. Morgan.

Eric Wang

Ms. Bartimer is an Associate of Arsenal for the healthcare team.  Prior to joining Arsenal in 2022, she was an investment banking Analyst at Morgan Stanley.

Julia Bartimer

Mr. Bruestle is an Accounting Manager of Arsenal. Prior to joining Arsenal in 2022,  he was a Senior Manager at PricewaterhouseCoopers. Previously, Mr. Bruestle was a Senior Auditor at Novak Francella LLC.

Stephen Bruestle

Ms. Montalvo is an Accountant.  Prior to joining Arsenal in 2022, she was an Associate in the finance department at Jeffries, LLC.  Previously, Jerrica was a Senior Accounting Specialist at Milliman, Inc.

Jerrica Montalvo

Mr. Schneider is a member of Arsenal’s Industrial Growth Advisory Board. Mr. Schneider held various executive and management roles at [Hexcel](/org/hexcel) Corporation for over 19 years, most recently as President of Industrial Materials and Global Fibers. Previously, he was a Director of Capital and Technology, Site Manager, and leader of different technical groups within [Hexcel](/org/hexcel), Meridian Automotive Systems, and Brunswick Boat Group.

Brett Schneider

Mr. Holland is a Vice President of Arsenal for the healthcare team. Prior to joining Arsenal in 2017, Mr. Holland was an Analyst at [Jefferies](/org/jefferies).

Taylor Holland

Ms. Zhang is the Vice President of Finance of Arsenal. Prior to joining Arsenal in 2016, she was a Manager in the asset management audit practice of PricewaterhouseCoopers.

Elisabetta Zhang

Mr. Phillippy is a Senior Advisor to the industrial growth team focused on crafting high-growth investment strategies in engineered components and systems, particularly in the photonics markets. Prior to beginning to work with Arsenal, he spent 20 years at Newport Corporation, a leading optics and photonics technology company, where he was most recently the President and CEO. Prior to Newport, Mr. Phillippy was with Schneider Electric, an electrical equipment and industrial controls manufacturer.

Robert Phillippy

Dr. Wiesman is a member of Arsenal’s Industrial Growth Advisory Board. He currently serves as a Senior Fellow for [General Atomics](/org/general-atomics). He has served as Executive Vice President and Chief Technology Officer at [QinetiQ North America](/org/qinetiq-north-america) since 2003. He is also a Professor of the Practice in the Department of Mechanical Engineering at the Massachusetts Institute of Technology. Previously, Dr. Wiesman held various senior management positions at the Electrical and Electronic Systems Group, Design and Systems Integration Group, and the Engineering Design Group.

Richard Wiesman

Sheebani Pradhan is a fund accountant at [Arsenal Capital Partners](/org/arsenal-capital-partners). Sheebani previously worked as an FSO assurance senior at EY from October 2018 to August 2021. Prior to that, they were a graduate assistant at [Bentley University](/org/bentley-university) from September 2017 to May 2018. Sheebani also interned at [Oscar de la Renta](/org/oscar-de-la-renta-llc) in the accounting department from June 2015 to August 2015.

Sheebani Pradhan has a Master of Science in Accounting from [Bentley University](/org/bentley-university) - McCallum Graduate School of Business, and a Bachelor of Commerce (B.Com.) with a focus in Accounting and Economics from the University of Toronto. Sheebani also has a background in Corporate Finance from [Columbia University](/org/columbia-university) in the City of New York.

Sheebani Pradhan reports to Frank Scrudato, CFO & Chief Compliance Officer. They are on a team with Victor Shaffer - Assistant Controller, Diana Danczuk - Senior Fund Accountant, and Julie Parisi - Fund Accountant.

Sheebani Pradhan

Julie Parisi is a fund accountant at Arsenal Capital Partners. Julie previously worked as an FSO assurance senior at EY from September 2018 to November 2020. In January 2017, they interned at EY in the assurance department. From May 2016 to July 2016, they interned at Hecht and Company P.C. as an accounting intern. In June 2015, they interned at Bold New York | The Way You Move.

Julie Parisi received their Master's degree in Accounting from [Tulane University](/org/tulane-university) - A.B. Freeman School of Business. Julie also holds a Bachelor of Science in Management (B.S.M.) with a concentration in Finance from [Tulane University](/org/tulane-university) - A.B. Freeman School of Business. Julie has also completed a study abroad program at Universidad Pontificia Comillas. Julie is a graduate of Scarsdale High School and is certified as a public accountant by the New York State Education Department.

Julie Parisi reports to Frank Scrudato, CFO & Chief Compliance Officer. They are on a team with Elisabetta Zhang - VP, Finance, Irina Avrorina - Accountant, and Victor Shaffer - Assistant Controller.

Julie Parisi

Mr. Evans is a member of Arsenal’s Healthcare Advisory Board. He is the former President and CEO of [Indiana University Health](/org/indiana-university-health-inc), a position he held for 14 years. He is currently the Vice Chair of the Indiana Commission to Combat Drug Abuse and an Adjunct Professor of Law at the McKinney School of Law. Mr. Evans also was a Partner at Baker & Daniels and served as Chair of the Federal Housing Finance Board for the George H.W. Bush administration.

Daniel Evans

Dr. Rothman is the Chair of Arsenal’s Healthcare Advisory Board. He also serves as the Wallace Professor of the Biomedical Sciences and Chair of the Department of Cell Biology at Yale University School of Medicine. Prior to joining the faculty at Yale in 2008, he served as Chief Scientist of General Electric Healthcare and its predecessor, Amersham. Dr. Rothman also served as an advisor to top research management at [Genentech](/org/genentech), Merck & Co., GlaxoSmithKline, and [Eli Lilly](/org/eli-lilly). He previously has been a professor at Stanford, Princeton, and Columbia universities and at Memorial Sloan-Kettering Cancer Center, where he served as Vice-Chairman of the Sloan-Kettering Institute. Dr. Rothman was the recipient of the 2013 Nobel Prize in Physiology or Medicine and the 2002 Albert Lasker Basic Medical Research Award.

James Rothman

Dr. Heimberger is a Senior Advisor for the healthcare team. She is currently a Professor in the Department of Neurosurgery at The University of Texas MD Anderson Cancer Center and has been a member of the department since 2002. Prior to joining MD Anderson, she was an Adjunct Associate and Assistant Professor for the Department of Neurosurgery, Division of Surgery at Baylor College of Medicine.

Amy Heimberger

Ms. Galloway is a member of Arsenal’s Industrial Growth Advisory Board. Ms. Galloway currently serves as Vice President Sales, Marketing & Innovation for DS Smith North America Packaging. Previously, she worked as the Global Director, Marketing and Strategy, at J.M. Huber Corporation and CEO at Universal Pasteurization & Universal Cold Storage. Ms. Galloway also served as Global President of Kemin Food Technologies and various other executive roles at [Kemin Industries](/org/kemin-industries).

Melanie Galloway

Ms. Cioffe is a member of Arsenal’s Industrial Growth Advisory Board. Prior to joining Arsenal, she was a Senior Vice President, Sustainability and Global Snacks R&D at [PepsiCo](/org/pepsico). She was with [PepsiCo](/org/pepsico) for ten years. Prior to [PepsiCo](/org/pepsico), Ms. Cioffe was at Merck & Co., Inc. for twenty years in various management positions.

Christine Cioffe

Mr. Lassiter is a member of Arsenal’s Healthcare Advisory Board. He currently serves as the President and CEO of the Henry Ford Health System, a leading integrated health system, and as Chair of the [American Hospital Association](/org/american-hospital-association-inc). Prior to joining the Henry Ford Health System in 2014, he was the CEO of [Alameda Health System](/org/alameda-health-system) for nine years. Mr. Lassiter also served as a Senior Vice President of Operations of JPS Health Network and Vice President of Dallas Methodist Medical Center for the Methodist Health System.

Wright Lassiter

Robbie Cahill is the current Principal at [Arsenal Capital Partners](/org/arsenal-capital-partners). Prior to joining Arsenal, Robbie worked as an Investment Banking Analyst for Bank of America Merrill Lynch in their Global Healthcare Group from July 2012 to June 2014. Robbie has a strong background in the financial industry and brings a wealth of experience to their current role.

Robbie Cahill has a Bachelor of Business Administration from the [University of Notre Dame](/org/university-of-notre-dame) in the field of finance.

They work with George Abd - Operating Partner, Marion Hayes - Senior Managing Director, Head of Responsible Investing, and Jeremy Goldberg - Operating Partner, Sourcing & Business Development. Their manager is Terry Mullen, Managing Partner.

Robbie Cahill

Joelle Marquis is the Senior Advisor of [Human Capital](/org/human-capital) at [Arsenal Capital Partners](/org/arsenal-capital-partners), a leading American private equity firm. Joelle has over two decades of experience in human resources and has held senior positions at some of the world's largest companies.

Marquis began their career in human resources at [Big Y](/org/big-y-foods-inc) Foods Inc., where they spent seven years as the Director of Human Resources. In this role, they were responsible for all aspects of the company's HR function, including recruitment, training, and employee relations.

After leaving [Big Y](/org/big-y-foods-inc), Marquis spent a year as the Director HR and internal consultant at National Grange Mutual, Main Street America. In this role, they provided HR support and advice to the company's management team.

In 1998, Marquis joined Information Systems and Services as the VP and GM. During their three-year tenure at the company, they oversaw a $1.5 billion increase in admitted assets in the property and casualty insurance business.

In 2001, Marquis joined Baltimore Technologies Inc. as the VP HR and COO. Baltimore Technologies was one of the world's leading "e-security" companies, with a strong portfolio of software-based security systems. Marquis was responsible for all aspects of the company's HR function, including recruitment, training, and employee relations.

After leaving Baltimore Technologies, Marquis joined [Arsenal Capital Partners](/org/arsenal-capital-partners) as the Senior Advisor of [Human Capital](/org/human-capital). In this role, they are responsible for advising the firm on all aspects of human capital management.

Joelle Marquis first earned their BSBA in Management from [Western New England University](/org/western-new-england-university). Joelle then went on to complete an Executive Program in Management at the University of Michigan. Finally, they earned their MSOD in Organizational Development from [American International College](/org/american-international-college).

Joelle Marquis

Tony Clewlow is a Senior Associate at [Arsenal Capital Partners](/org/arsenal-capital-partners). Tony joined the company in July 2018 after working as a Private Equity Associate at [Water Street Healthcare Partners](/org/water-street-healthcare-partners) for three years. Prior to that, they were a Healthcare Investment Banking Analyst at [Jefferies](/org/jefferies) for two years.

Tony has a bachelor's degree in finance from the [University of Pennsylvania](/org/university-of-pennsylvania). Tony is originally from Philadelphia, Pennsylvania.

Tony Clewlow attended the University of Michigan - Stephen M. Ross School of Business and earned a Bachelor's Degree in Business Administration. Tony is also certified by FINRA in Series 63 and Series 79.

Tony Clewlow

Michael Bernstein is an Operating Partner at [Arsenal Capital Partners](/org/arsenal-capital-partners), a private equity firm focused on investments in the Healthcare sector. Prior to joining Arsenal, Bernstein served as Partner with Baird Capital's US Private Equity Team.

Bernstein has over 20 years of experience in the Healthcare industry. Michael served as President & CEO of CAE Healthcare, a provider of healthcare simulation solutions, from July 2009 to April 2014. Michael also served as CEO of Innovative Health Strategies, Inc. from January 2004 to November 2007. In this role, they were responsible for leading the company's growth strategy and executing a successful sale of the company to a private equity firm. Prior to that, they served as President & COO of Cobalt Corp, a publicly traded holding company for Blue Cross Blue Shield of Wisconsin, from January 2000 to October 2003.

Michael Bernstein received a J.D. from the University of the Pacific - McGeorge School of Law and a B.A. in Rhetoric, Political Science from the University of California, Davis.

Michael Bernstein reports to Terry Mullen, Managing Partner. They are on a team with Roy Seroussi - Investment Partner, Michelle Nasir - Chief Talent Officer, and Matthew Whitman - Investment Partner, Head of Origination.

Michael Bernstein

Sal Gagliardo is an operating partner at [Arsenal Capital Partners](/org/arsenal-capital-partners). Sal has over 25 years of experience in the specialty chemicals industry, including serving as vice president of strategy and business development at Vertellus Specialties Inc. and president and general manager of Cambrex Corporation's Rutherford Chemicals Division. Prior to that, they held various engineering and operations management roles at BASF Corp, Reichold Chemicals, and FMC Corp.

Sal Gagliardo has a Master of Science (M.S.) in International Management Science from the [New Jersey Institute of Technology](/org/new-jersey-institute-of-technology) - School of Management and a Bachelor of Science (B.S.) in Chemical Engineering from the [New Jersey Institute of Technology](/org/new-jersey-institute-of-technology).

Sal Gagliardo reports to Terry Mullen, Managing Partner. They are on a team with Michael Mclean - Director, Information Technology, Bob Farmer - VP, Strategy & Research, and John Mattison - Operating Partner & Chief Medical Information Officer.

Sal Gagliardo

Terry Mullen is the managing partner at [Arsenal Capital Partners](/org/arsenal-capital-partners). Terry has over 25 years of experience in the private equity industry. Prior to joining Arsenal, Mullen was a Principal at Thomas H. Lee Partners from 1992 to 2000. Terry also worked as an investment banker at [Morgan Stanley](/org/morgan-stanley) from 1990 to 1992. Mullen has a bachelor's degree from the [University of Pennsylvania](/org/university-of-pennsylvania) and an MBA from [Harvard Business School](/org/harvard-business-school).

Terry Mullen has an MBA from [Harvard Business School](/org/harvard-business-school) and a BBA in Finance & Economics from the [University of Notre Dame](/org/university-of-notre-dame).

Ryan Berman - Principal, John Televantos - Senior Partner, and Brian Orkin - Investment Partner report to Terry Mullen.

Terry Mullen

Bg Porter is currently an Operating Partner at [Arsenal Capital Partners](/org/arsenal-capital-partners). Bg has previously held positions at Henry Ford Health System, Hopebridge, and [Arsenal Capital Partners](/org/arsenal-capital-partners). From 2011 to 2015, they were a Managing Director at Huron Consulting Group. From 2001 to 2015, they were the President and CEO of Studer Group.

Bg Porter has a degree in Political Science from [Stanford University](/org/stanford), with Honors. They also have a Master of Social Science in Asian Government from the University of Queensland. Lastly, they have an MBA from [Harvard University](/org/harvard).

Bg Porter reports to Terry Mullen, Managing Partner. They are on a team with Michael Mclean - Director, Information Technology, Matthew Whitman - Investment Partner, Head of Origination, and Jonathan Laifer - Principal.

Bg Porter

Robert Weiner is currently an associate at [Arsenal Capital Partners](/org/arsenal-capital-partners). Prior to joining Arsenal, they worked as an investment banking analyst at Raymond James from June 2019 to July 2021, where they were part of the Diversified Industrials Group. From June 2018 to August 2018, they worked as an investment banking summer analyst in the Financial Services Group at Raymond James. In summer 2017, they were a summer analyst at Skyway Group Private Equity Funds.

Robert Weiner attended the [University of Virginia](/org/university-of-virginia), where they earned their Bachelor of Arts in Economics and Applied Statistics. Robert also attended Robinson High School.

Robert Weiner

Richard Eglen is a Senior Advisor at [Arsenal Capital Partners](/org/arsenal-capital-partners). Richard has over 30 years of experience in the pharmaceutical and biotech industries. 

Richard began their career as a Research Scientist at Smith and Nephew. Richard then joined Syntex as Vice President of Neurosciences. In 1994, they became Vice President of the Institute of Pharmacology at Roche Bioscience. 

In 2000, Richard joined DiscoverX as Chief Scientific Officer. Richard was with the company for six years before joining [Arsenal Capital Partners](/org/arsenal-capital-partners). 

Most recently, Richard was Vice President and General Manager at Corning Incorporated. Richard was with the company for eight years before returning to [Arsenal Capital Partners](/org/arsenal-capital-partners) in 2019.

Richard Eglen was educated at [Nottingham Trent University](/org/nottingham-trent-university), where they received their Ph.D. in Pharmacology. Richard also has a B.Sc. in Special Honours Physiology from [The University of Sheffield](/org/the-university-of-sheffield).

Richard Eglen

Sameen Ahmed is an Administrative Assistant at [Arsenal Capital Partners](/org/arsenal-capital-partners). Sameen previously worked as an Office Manager at [IA Interior Architects](/org/ia-interior-architects) from October 2019 to April 2020. Prior to that, they were a Studio Assistant at Fawn Galli Interiors from September 2018 to May 2019. Sameen also worked as an Administrative Assistant at The Jordan Company from August 2012 to May 2018.

Sameen Ahmed has a BA in Business/Corporate Communications from [Baruch College](/org/baruch).

Sameen Ahmed

Robert Sorrel is a Principal at [Arsenal Capital Partners](/org/arsenal-capital-partners). Prior to joining Arsenal, Robert was a Principal at Apollo Global Management Inc. from August 2016 to February 2021. From August 2014 to July 2016, Robert was an Associate at [Leonard Green & Partners](/org/leonard-green-partners). Robert began their career in investment banking as a Healthcare Investment Banking Analyst at [Morgan Stanley](/org/morgan-stanley) from June 2012 to July 2014. Robert also worked as an Investment Banking Summer Analyst at [Morgan Stanley](/org/morgan-stanley) from June 2011 to August 2011. Robert's experience also includes internships at Crestview Partners, LLC from June 2010 to July 2010 and at [Tailwind Capital](/org/tailwind-capital) from June 2009 to July 2009.

Robert Sorrel has a field in economics and they went to [Amherst College](/org/amherst-college) for their schooling.

Robert Sorrel reports to Terry Mullen, Managing Partner. They are on a team with Patrick Flynn - Director, Technology, Tim Zappala - Senior Partner, and Steve Mclean - Senior Partner.

Robert Sorrel

Rick Li is a senior associate at [Arsenal Capital Partners](/org/arsenal-capital-partners). Rick has over five years of experience working in the finance industry. Rick started their career as an investment banking analyst at [Goldman Sachs](/org/goldman-sachs). Rick then transitioned to private equity and joined [The Carlyle Group](/org/the-carlyle-group) in August 2017. Rick has been with [Arsenal Capital Partners](/org/arsenal-capital-partners) since April 2021.

Rick Li graduated from the Red McCombs School of Business at the University of Texas at Austin with a Bachelor of Business Administration (B.B.A.) in accounting. Rick then went on to earn their Master of Professional Accounting (MPA) from the same school.

Rick Li

Jon Mattern is the current Vice President at [Arsenal Capital Partners](/org/arsenal-capital-partners), a position they have held since December of 2015. Prior to their current role, Jon worked as an Analyst at [Centerview Partners](/org/centerview-partners) from June 2012 until December 2015. Before their time at [Centerview Partners](/org/centerview-partners), Jon was a Summer Analyst at Belvedere Asset Management, LLC from July 2011 until August 2011.

Jon Mattern has a B.A. in Economics, Finance, and Computer Science from [Princeton University](/org/princeton), and they attended Delbarton School.

They are on a team with Patrick Flynn - Director, Technology, Jonathan Laifer - Principal, and Marion Hayes - Senior Managing Director, Head of Responsible Investing. Jon Mattern reports to Terry Mullen, Managing Partner.

Jon Mattern

Frank Scrudato is currently the CFO & Chief Compliance Officer at [Arsenal Capital Partners](/org/arsenal-capital-partners). Prior to joining Arsenal, they were the Director of Corporate Development at [Asbury Automotive Group](/org/asbury-automotive-group) from January 2004 to November 2005. Before that, they were a Director at KPMG LLP from June 2002 to January 2004.

In November 2005, Frank joined Bruckmann, Rosser, Sherrill & Co. as their CFO and Principal. Frank held this position until January 2014. Prior to Bruckmann, Rosser, Sherrill & Co., Frank was a Manager at Arthur Andersen LLP from September 1997 to June 2002.

Frank Scrudato's educational career began at [Rutgers University](/org/rutgers-university).

Irina Avrorina - Accountant, Victor Shaffer - Assistant Controller, and Julie Parisi - Fund Accountant report to Frank Scrudato. Frank Scrudato works with Roy Seroussi - Investment Partner, John DiGiovanni - Investment Partner, and Jonathan Laifer - Principal. Frank Scrudato reports to Terry Mullen, Managing Partner.

Frank Scrudato

Dr. June is a Senior Advisor for the healthcare team. He is the Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the [University of Pennsylvania](/org/university-of-pennsylvania). He also serves as the Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine and the Director of the [Parker Institute for Cancer Immunotherapy](/org/parker-institute-for-cancer-immunotherapy) at the [University of Pennsylvania](/org/university-of-pennsylvania). Dr. June has been a member of the department since 1999. Prior to joining the [University of Pennsylvania](/org/university-of-pennsylvania), he was a Professor of Medicine and of Cell and Molecular Biology at the Uniformed Services University for the Health Sciences, and the Head of the Department of Immunology and Founder of the Immune Cell Biology Program at the Naval Medical Research Center.

Carl June

Thomas E. Tuft serves as a Firm Advisor of Arsenal. Mr. Tuft was Chairman of the Global Capital Markets Advisory and Vice Chairman of US Investment Banking at Lazard Ltd. from 2009 - 2018. Previously, he was with [Goldman Sachs](/org/goldman-sachs) & Co. in a variety of key positions. He joined [Goldman Sachs](/org/goldman-sachs) in 1976 as Vice President in Institutional Sales and co-founded its Equity Capital Markets business in 1985, becoming General Partner in 1986. He served as Head of the Global Equity Capital Markets business beginning in 1988 and Chairman of the Global Capital Markets Group at [Goldman Sachs](/org/goldman-sachs) & Co. since 2004. For over 25 years, he led a key role in a variety of equity offerings in the U.S. and landmark privatizations worldwide, including solicitation, marketing, management, and pricing of domestic and international equity issues.

Thomas E. Tuft

Dr. McClellan is a member of Arsenal’s Healthcare Advisory Board. He currently serves as the Robert J. Margolis Professor of Business, Medicine, and Policy and founding Director of the Duke-Margolis Center for Health Policy at [Duke University](/org/duke-university). Prior to joining Duke in 2016, he spent nine years at the Brookings Insitution, most recently serving as a Senior Fellow in Economic Studies and as a Director of the Health Care Innovation and Value Initiatives. Prior hereto, Dr. McClellan served as an Associate Professor, Department of Economics and Department of Medicine for [Stanford University](/org/stanford). Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA).

Mark McClellan

Dr. Slavin is a member of Arsenal’s Healthcare Advisory Board. He currently serves as the President of Massachusetts General Hospital, a position that he has held for 18 years. Dr. Slavin is also a Professor of healthcare policy of Harvard Medical School. Prior to joining Massachusetts General Hospital, he served as the Chairman and CEO of the Massachusetts General Physicians Organization for three years. Prior hereto, Dr. Slavin served as President of Barnes-Jewish Hospital and Senior Vice President and Chief Medical Officer of Massachusetts General Hospital.

Peter Slavin

Ms. Wagner is an Office Manager and Senior Executive Assistant of Arsenal. Prior to joining Arsenal in 2013, she was an Executive Assistant to the Executive Vice President of Operations & Supply Chain at Gurwitch Products. Previously, she was an Investment Relations Coordinator at Entrust Capital. She also has worked at [Jose Cuervo](/org/becle).

Sandra Wagner

Dr. Getz is a Senior Advisor for the healthcare team.  He currently is the Executive Director of the Tufts Center for the Study of Drug Development at [Tufts University](/org/tufts-university) School of Medicine.  Prior to joining Tufts, he was the Founder and Board Chair of the Center for Information & Study on Clinical Research Participation and the Founder and CEO of CenterWatch.

Ken Getz

George Abd is an experienced executive in the packaging industry, with a history of successful leadership in both public and private companies. George currently serves as Operating Partner at [Arsenal Capital Partners](/org/arsenal-capital-partners), a private equity firm specializing in investments in lower middle market specialty industrials and healthcare companies. Prior to their current role, George served as CEO and President of Spartech LLC, a leading provider of plastic sheet, roll stock, and specialty packaging products. George also served on the board of Anchor Packaging, one of the largest suppliers of rigid plastic packaging products in North America.

George’s career in the packaging industry began at [Pretium](/org/pretium) Packaging, where they served as CEO and President for more than 8 years. During their tenure, George led the company’s growth from $160 million in revenue to $300 million, while tripling EBITDA. Under George’s leadership, [Pretium](/org/pretium) completed three acquisitions and consolidated 5 manufacturing locations. George also successfully sold the company to two different Private Equity Owners in 2010 and 2014 respectively.

George has also served on the Advisory Board of Chemline for 9 years. In this role, they provide strategic guidance to the company on a variety of issues, including operations, marketing, and business development.

George’s experience and success in both public and private companies makes him uniquely qualified to serve as an Operating Partner at [Arsenal Capital Partners](/org/arsenal-capital-partners). Their deep knowledge of the packaging industry and proven track record of growing businesses makes him an invaluable asset to the firm and its portfolio companies.
George Abd attended the [University of Notre Dame](/org/university-of-notre-dame) for both their undergraduate and graduate degrees. George earned a Bachelor of Arts in Economics in 1985 and a Master of Business Administration in 1987.


George Abd

Ms. Gambardella is a Senior Associate of Arsenal.  Prior to joining Arsenal in 2021, she was an Associate at [Spencer Stuart](/org/spencer-stuart).

Lauren Gambardella

Mr. Mansfield is a Principal of Arsenal for the industrial growth team. Prior to joining Arsenal in 2021, he was a Vice President of [Brentwood Associates](/org/brentwood-associates) and FFL Partners. Previously, he was an Associate of [Berkshire Partners](/org/berkshire-partners) and an Analyst in the global industrial group of [Morgan Stanley](/org/morgan-stanley).

Alex Mansfield

Garry Nolan is currently a Senior Advisor at [Arsenal Capital Partners](/org/arsenal-capital-partners). Garry has also previously worked at Apprise Biotech, Inc, Nodality Inc., and Rigel. 

Garry Nolan's most notable previous position was at Rigel, where they were the Scientific Founder. There, they created original technology for peptide expression/screening inside cells as drug surrogate. This technology was used to make viruses that made cells "healthier". Garry Nolan was at Rigel from March 1995 to March 2001. 

Before Rigel, Garry Nolan worked at [Stanford University](/org/stanford).

Garry Nolan pursued a postdoc fellowship in biochemistry at the Massachusetts Institute of Technology after receiving their Ph.D. in genetics from [Stanford University](/org/stanford) School of Medicine. Garry completed their undergraduate degree in genetics at [Cornell University](/org/cornell-university).

Garry Nolan

Mr. Sriram is an Associate of Arsenal where he focuses on executing transactions and overseeing portfolio companies for the industrial growth team.  Prior to joining Arsenal in 2021, Mr. Sriram was an investment banking Associate at [Goldman Sachs](/org/goldman-sachs).  Previously, he was an Analyst at [Houlihan Lokey](/org/houlihan-lokey).  

Harish Sriram

Joe Rooney is an investment partner at [Arsenal Capital Partners](/org/arsenal-capital-partners). Joe has previous experience working as an investment banker and financial analyst at [Citigroup](/org/citigroup) and GSC Group. Joe has a bachelor's degree in finance from the [University of Notre Dame](/org/university-of-notre-dame).

After graduating from Half Hollow Hills High School East, Joe Rooney attended [Northwestern University](/org/northwestern-university) where they obtained their BA in Mathmatical Methods in the Social Sciences / Economics.

They work with Bob Farmer - VP, Strategy & Research, Patrick Flynn - Director, Technology, and John Televantos - Senior Partner. Joe Rooney reports to Terry Mullen, Managing Partner.

Joe Rooney

Tom Bartley is a Senior Advisor for the healthcare team.  He currently serves as the leader in the industry practice of Google.  Mr. Bartley is also the President of TAB Consulting.  Prior to joining Google in 2010, he served as the Chief Marketing Officer of Sears Holding Corporation.  Prior hereto, Mr. Bartley served as the Vice President, Brand Management of K-Mart.

Tom Bartley

John DiGiovanni is an investment partner at [Arsenal Capital Partners](/org/arsenal-capital-partners), a leading private equity firm that specializes in investments in middle-market healthcare and specialty industrials companies. DiGiovanni has over 20 years of experience in the healthcare industry and has been with Arsenal since its inception in 2000. John has raised institutional equity investment funds of $5.3 billion, completed more than 40 platform investments, and achieved 30 realizations.

DiGiovanni also serves on the board of directors for Best Value Healthcare, LLC, Hopebridge, ACCUMEN Inc., Music for Autism, and Gilda's Club New York City. John is the chairman of the board of directors for Gilda's Club New York City.

Prior to joining Arsenal, DiGiovanni was a principal at Baird Capital for 10 years. John has a bachelor's degree from the [University of Notre Dame](/org/university-of-notre-dame) and an MBA from Columbia Business School.

This person works with John DiGiovanni on the investment team.

John DiGiovanni

Brian Orkin is an investment partner at [Arsenal Capital Partners](/org/arsenal-capital-partners). Brian has over 12 years of experience in the industry and has been with Arsenal for over 4 years. Prior to joining Arsenal, Brian was a principal at The Anderson Group LLC, a co-founder at Gulf Atlantic Financial Group, Inc., and a co-founder at Phoenix Capital Group, Inc. Brian also spent two years as an associate at Buchanan Ingersoll P.C. and three years as an associate at Doepken Keevican & Weiss P.C.
Brian Orkin has an MBA from the University of Pittsburgh Katz Graduate School of Business and a law degree from California Western School of Law. Brian also has a bachelor's degree from the University of Michigan.


Brian Orkin

Michelle Nasir is the current Chief Talent Officer at [Arsenal Capital Partners](/org/arsenal-capital-partners). Michelle has held this position for 2 years and 7 months. Prior to their current role, Michelle served as the Chief Talent Officer at United States Steel Corporation for 1 year and 7 months. Michelle has also been a Partner, Leadership Consulting at [Heidrick & Struggles](/org/heidrick-struggles) for 8 years, Director, People Operations at Google for 1 year, Vice President, Operations Effectiveness and Planning at AOL, Time Warner for 1 year, and Director/Team Leader, Worldwide Organizational Effectiveness & Internal Consulting at [Pfizer](/org/pfizer) for 6 years. In addition, Michelle has experience as a Manager at [McKinsey & Company](/org/mckinsey-company) for 3 years and Ernst and Young for 4 years. Michelle started their career as a Manager at [Accenture](/org/accenture) for 2 years.



Michelle Nasir

Mr. Whitman is an Investment Partner, Head of Origination where he focuses on business development and sourcing transactions for the healthcare team. Prior to joining Arsenal in 2022, he was a Principal of [Windham Venture Partners](/org/windham-venture-partners). Previously, Mr. Whitman was an Executive Director in the healthcare investment banking group at [Morgan Stanley](/org/morgan-stanley) and a Vice President of [Citigroup](/org/citigroup). Mr. Whitman also worked at Monitor Group as a Consultant.

Matthew Whitman

Mr. Goldberg is an Operating Partner of Arsenal where he he focuses on networking and sourcing transactions for the healthcare team. Prior to joining Arsenal in 2014, Mr. Goldberg was a Managing Director, Corporate Development of Endo Pharmaceuticals. Previously, he was a founding Partner of ProQuest Investments and the founding CEO or founder of three biotechnology companies that were acquired or taken public, including [Versicor](/org/versicor) and [Becton Dickinson](/org/becton-dickinson).

Jeremy Goldberg

Mr. Shaffer is an Assistant Controller of Arsenal. Prior to joining Arsenal in 2019, he was a Senior Associate in the alternative investment practice of PricewaterhouseCoopers. Previously, Mr. Shaffer was also an Assurance Associate at PricewaterhouseCoopers.

Victor Shaffer

Ms. Heath is an Executive Assistant of Arsenal. Prior to joining Arsenal in 2018, she was an Executive Assistant at [Meridian Capital Group](/org/meridian-capital-group). Previously, she was an Administrative Assistant & Bookkeeper at Mercury Mechanical Services.

Larissa Heath

Mr. Teller is a Vice President of Arsenal for the industrial growth team. Prior to joining Arsenal in 2020, he was an Associate at [Kelso & Company](/org/kelso-company). Previously, he was an investment banking Analyst at [Barclays](/org/barclays).

Matthew Teller

Ms. Danczuk is a Senior Fund Accountant of Arsenal. Prior to joining Arsenal in 2018, she was a Senior Accountant of [Fortress Investment Group](/org/fortress-investment-group-llc). Previously, Ms. Danczuk was an Assurance Experienced Associate at PricewaterhouseCoopers.

Diana Danczuk

Ms. Canty is a Senior Executive Assistant of Arsenal. Prior to joining Arsenal in 2017, she was an Executive Assistant to the CEO at Glenview Capital. Previously, she was an Executive Assistant at [Reservoir Capital Group](/org/reservoir-capital-group). She also has worked at Pelham Holdings and Christie’s Auction House.

Jenna Canty

Ms. Balkumar is a Senior Executive Assistant of Arsenal. Prior to joining Arsenal in 2013, she was an Executive Assistant to the Executive Vice President of Operations & Supply Chain at DOAR Litigation Consulting. Previously, she was an Investment Relations Coordinator at Tache. She also worked at Farfan & Mendes.

Maya Balkumar

Mr. Chan is a Vice President of Arsenal for the industrial growth team.  Prior to joining Arsenal in 2018, Mr. Chan was an investment banking Analyst at J.P. Morgan.

Ian Chan

Mr. Niehaus is a Senior Associate of Arsenal for the healthcare team. Prior to joining Arsenal in 2019, Mr. Niehaus was an Associate at [Audax Group](/org/audax-management-company-inc-llc).

Blake Niehaus

Mr. Berman is a Principal of Arsenal for the industrial growth team. Prior to joining Arsenal in 2013, he was an investment banking Analyst at [Credit Suisse](/org/credit-suisse).

Ryan Berman

Mr. Laifer is a Principal of Arsenal for the healthcare team. Prior to joining Arsenal in 2020, Mr. Laifer was a Vice President at [BelHealth Investment Partners](/org/belhealth-investment-partners). Previously, he was an Investment Banking Associate in the healthcare group at [Goldman Sachs](/org/goldman-sachs).

Jonathan Laifer

Ms. Thompson is the IT Manager of Arsenal. Prior to joining Arsenal in 2011, she was the Office Operations and Facilities Manager at Akana Capital. Before that, she was the Office Manager at [Westbrook Partners](/org/westbrook-partners).

Betty Thompson

Ms. Redpath is an Executive Assistant of Arsenal. Prior to joining Arsenal in 2018, she was a Production Manager at Broadstreet.

Karly Redpath

Ms. Mason is an Assistant Controller of Arsenal. Prior to joining Arsenal in 2020, she was a Controller at Staple Street Capital. Previously, Ms. Mason was a Financial Controller at Aretex Capital Partners and a Financial Controller at ZZ Capital International. She also has worked at [Kinderhook Industries](/org/kinderhook-industries) and [Deloitte](/org/deloitte).

Sarah Mason

Ms. Avrorina is a Senior Accountant of Arsenal.  Prior to joining Arsenal in 2018, she was a Staff Auditor at Prager Metis CPA.  Previously, Ms. Avrorina was a Staff Accountant at Genesis Philanthropy Group and a Full Charge Bookkeeper at Cinderella Travel.

Irina Avrorina

Mr. Rossi is a Senior Advisor for the industrial growth team. Mr. Rossi previously served as interim CEO and an advisor to the board of directors of Elite Comfort Solutions, a former Arsenal portfolio company. Mr. Rossi also served as President and CEO of Balchem Corporation for 17 years and has held leadership positions at NoritAmericas and Oakite Products.

Dino Rossi

Mr. Knight is a Senior Advisor for the industrial growth team.  Prior to beginning to work with Arsenal in 2017, Mr. Knight held several leadership roles at The [Sherwin-Williams](/org/sherwin-williams), Rubbermaid, [Procter & Gamble](/org/procter-gamble), and the U.S. Army.  During his 22 years at [Sherwin-Williams](/org/sherwin-williams), he served as President of the Diversified Brands Division, the Global Group, and the Latin America Coatings Group.

Tim Knight

Ms. Witz is a member of Arsenal’s Healthcare Advisory Board. She currently serves as the Founder, President, and CEO of PWH Advisors. Ms. Witz was an Executive Vice President at [Sanofi](/org/sanofi). Prior hereto, she worked at [GE Healthcare](/org/ge-healthcare-limited) for 17 years in various leadership roles, most recently being President and CEO of GE’s pharmaceutical business.

Pascale Witz

Mr. Juneau is a is a member of Arsenal’s Industrial Growth Advisory Board. He currently serves as an advisor to Lithium Royalty Corporation, and previously served as Executive Vice President, Corporate Strategy & Investor Relations at [Albemarle](/org/albemarle). During his career at [Albemarle](/org/albemarle), he also worked in various senior roles including President of Performance Chemicals, Vice President of Polymer Solutions, and Vice President of Global Sales & Services.

Matt Juneau

Mr. Calabretta is a member of Arsenal’s Industrial Growth Advisory Board. He currently serves as Vice President, Global Indirect Procurement at [CommScope](/org/commscope). Mr. Calabretta was Vice President, Global Indirect Procurement at [Campbell Soup Company](/org/campbell-soup-company) and worked in leadership positions at [Johnson & Johnson](/org/johnson-johnson) for over 25 years.

Chris Calabretta

Mr. Williams is a Senior Advisor for the healthcare team and the CEO of Pharma Value Demonstration, an Arsenal portfolio company. Prior to joining Arsenal as a Senior Advisor, he was Founder and CEO of Evidera. Previously, Mr. Williams was a Senior Vice President at United BioSource Corporation and also worked at Boston Consulting Group and The Monitor Group.

Jon Williams

Mr. Wall is a member of Arsenal’s Industrial Growth Advisory Board. Most recently, he was the Chief Technology Officer for HP since 2012. Prior to joining HP, he spent 14 years at Intel where he held various senior management roles. He has also served on the President’s Council of Advisors on Science and Technology.

Shane Wall

Mr. Castell is a member of Arsenal’s Healthcare Advisory Board. He is the former Chair of the [Wellcome Trust](/org/wellcome-trust). Prior to his time at the [Wellcome Trust](/org/wellcome-trust), he served as Chair and Partner of Ondra. Previously, he held CEO and executive positions at [GE Healthcare](/org/ge-healthcare-limited), [General Electric](/org/general-electric), [GE Healthcare](/org/ge-healthcare-limited) Bio-Sciences Corp., and Amersham.

William Castell

Robert Accordino is a member of Arsenal’s Healthcare Advisory Board. He currently serves as the Chief Mental Health Officer of [Quartet Health](/org/quartet-health). Mr. Accordino is also an Attending Physician at Massachusetts General Hospital. Prior to joining [Quartet Health](/org/quartet-health) in 2018, he served as the Chief of Psychiatry & Behavioral Health at CareMore Health. Prior hereto, Mr. Accordino served as the White House Fellow to the Secretary of Defense. Mr. Accordino is also the Founder of Music for Autism, a non-profit that organizes professional music concerts specifically for individuals with autism and their families.

Robert Accordino

Dr. Hayworth is a member of Arsenal’s Healthcare Advisory Board. For over 20 years, Dr. Hayworth served as the President and CEO of [CareMount Medical](/org/caremount-medical-p-c), the largest independent multi-specialty medical group in the United States. CareMount is now part of Optum Health and at Optum, he currently serves as the President, Optum Tri-State. Prior to joining CareMount, Dr. Hayworth was a Clinical Assistant Professor of Obstetrics, Gynecology, and Reproductive Services at the Icahn School of Medicine at Mount Sinai. Dr. Hayworth has also served as the Associate Dean of the Icahn School of Medicine at Mount Sinai.

Scott Hayworth

Mr. Bevilaqua serves as a Senior Advisor for the industrial growth team. Prior to joining Arsenal as a Senior Advisor, he spent 17 years at [Hexion](/org/hexion-inc) in various senior management positions. In addition, he has served in executive leadership positions at Alusuisse Lonza, Russell-Stanley Holdings, Woodbridge Foam Corporation, and GE Plastics.

Jody Bevilaqua

Dr. Demetri is a Senior Advisor for the healthcare team.  He currently serves as the Director of the Center for Sarcoma and Bone Oncology at the [Dana-Farber Cancer Institute](/org/dana-farber-cancer-institute-inc), Director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, and as the Executive Director for Clinical and Translational Research at the Ludwig Institute for Cancer Research.  He is also a Professor of Medicine at Harvard Medical School.  Prior to joining the [Dana-Farber Cancer Institute](/org/dana-farber-cancer-institute-inc), he worked at the National Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Somerville Hospital, and Pacific Medical Center.

George Demetri

Dr. Raymond is a member of Arsenal’s Industrial Growth Advisory Board and is the CEO of Monument Chemical. Prior to joining Monument Chemical, Dr. Raymond was the CEO of Sonneborn for six years. Previously, he served as President of Ashland Water Technologies and has also held executive positions at [General Electric](/org/general-electric), [Honeywell](/org/honeywell), and Hercules.

Paul Raymond

Dr. Scher is a Senior Advisor for the healthcare team. He currently serves as the Head of the Biomarker Development Program and is the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Scher has served as a Professor of Medicine at Weill Cornell Medical College since 2000. He joined Memorial Sloan-Kettering in 1992 as the Chief of Genitourinary Oncology Service. Previously, he was a Principle Investigator for the Department of Defense prostate cancer research program and a Researcher for the Prostate Cancer Foundation.

Howard Scher

Mr. Nolan is a Senior Advisor for the industrial growth team and serves as the Chair of Polytek, an Arsenal portfolio company. Prior to joining Arsenal as a Senior Advisor, he was President and CEO of [Kennametal](/org/kennametal), spent seven years at [Avery Dennison](/org/avery-dennison), and 12 years at Valspar. He has held various roles at Loctite Corporation, Ashland, [General Electric](/org/general-electric), and The Timken Company.

Don Nolan

The board of directors at Arsenal Capital Partners has a history of experience with companies such as Blue Cross Blue Shield of Massachusetts, Rigel Inc., Memorial Sloan-Kettering Cancer Center, and ABB. They also have a wide range of education, including English, Biochemistry, Genetics, Management, Organizational Development, Medicine, Health Services Research, Business, Pharmacology, and Physiology.

Board of Directors

About

Team members

Other teams at Arsenal Capital Partners

Leadership Team

CEO and Executive Team

Discover similar companies